Cas No.: | 1164462-05-8 |
Chemical Name: | TG4-155 |
Synonyms: | TG 4-155;(E)-N-(2-(2-Methyl-1H-indol-1-yl)ethyl)-3-(3,4,5-trimethoxyphenyl)acrylamide;(2E)-N-[2-(2-Methyl-1H-indol-1-yl)ethyl]-3-(3,4,5-trimethoxyphenyl)-2-propenamide;(E)-N-[2-(2-methylindol-1-yl)ethyl]-3-(3,4,5-trimethoxyphenyl)prop-2-enamide;YBHUXHFZLMFETJ-MDZDMXLPSA-N;SMR000237431;MLS000724641;GTPL5818;SYN5120;AOB1790;HMS2242E03;BCP25837;TG4155;BDBM50016949;TG4 155;Q27088974;(2E)-N-[2-(2-methyl-1H-indol-1-yl)ethyl]-3-(3,4,5-trimethoxyphenyl)acrylamide;(2E)-N-;TG4-155;AS-16484;CHEMBL1368005;EX-A2930;HY-18971;1164462-05-8;CS-0014805;F20810;NSC767453;(E)-N-(2-(2-methyl-1H-indol-1-yl)ethyl)-3-(3,4,5-trimethoxyphenyl)acrylamide;(2E)-N-[2-(2-Methyl-1H-indol-1-yl)ethyl]-3-(3,4,5-trimethoxyphenyl)-2-propenamide;;NSC-767453;(E)-N-(2-(2-methylindol-1-yl)ethyl)-3-(3,4,5-trimethoxyphenyl)prop-2-enamide;s6793;TG4-155?;AKOS001816787;DA-78369;SCHEMBL14333686 |
SMILES: | O=C(/C=C/C1C=C(C(=C(C=1)OC)OC)OC)NCCN1C(C)=CC2C=CC=CC1=2 |
Formula: | C23H26N2O4 |
M.Wt: | 394.463546276093 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | TG4-155 is a potent, brain-permeant and selective EP2 receptor antagonist with a Ki of 9.9 nM[1][2]. TG4-155 shows low nanomolar antagonist activity against only EP2 and DP1[1]. TG4-155 has an EP2 Schild KB of 2.4 nM and displays 550-4750-fold selectivity for EP2 over EP1, EP3, EP4 and IP, but only 14-fold selectivity against the DP1 receptor[2]. |
Target: | EP2 Receptor:9.9 nM (Ki) |
References: | [1]. Jiang J, et al. Role of prostaglandin receptor EP2 in the regulations of cancer cell proliferation, invasion, and inflammation. J Pharmacol Exp Ther. 2013 Feb;344(2):360-7. [2]. Ganesh T. Prostanoid receptor EP2 as a therapeutic target. J Med Chem. 2014 Jun 12;57(11):4454-65. |